Recruiting OBSERVATIONAL NCT06609668

Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ) (THROPIQ)

Sponsor: Centre Hospitalier Universitaire Dijon

Conditions Giant Cell Arteritis (GCA) Polymyalgia Rheumatica (PMR)

Updated 4 times since 2024 Last updated: Sep 2, 2025 Started: Oct 10, 2024 Primary completion: Oct 31, 2027 Completion: Oct 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06609668, this observational or N/A phase trial focuses on Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR) and remains actively recruiting participants. Sponsored by Centre Hospitalier Universitaire Dijon, it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Oct 2025 — Present [monthly]

Recruiting
Feb 2025 — Oct 2025 [monthly]

Recruiting
Dec 2024 — Feb 2025 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Oct 2024 — Dec 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Universitaire Dijon

Data source: Centre Hospitalier Universitaire Dijon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dijon, France